Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02642809 |
|
Recruitment Status :
Completed
First Posted : December 30, 2015
Last Update Posted : November 24, 2021
|
Sponsor:
Washington University School of Medicine
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Washington University School of Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | September 24, 2020 |
| Actual Study Completion Date : | August 3, 2021 |